A retrospective review of memantine use and COVID-19-associated mortality from a national database.
作者信息
Park Moon Ho, Kwon Do Young
机构信息
Department of Neurology, Korea University Ansan Hospital, Ansan, Republic of Korea.
出版信息
J Med Virol. 2021 Jan;93(1):168-169. doi: 10.1002/jmv.26266. Epub 2020 Jul 14.
Abstract
摘要
相似文献
1
A retrospective review of memantine use and COVID-19-associated mortality from a national database.一项基于国家数据库对美金刚使用情况与新冠病毒疾病相关死亡率的回顾性研究。
J Med Virol. 2021 Jan;93(1):168-169. doi: 10.1002/jmv.26266. Epub 2020 Jul 14.
2
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.美金刚及相关金刚烷类药物（如金刚烷胺）减轻新冠病毒疾病神经毒性作用（包括急性呼吸窘迫综合征）以及通过溶酶体效应减少病毒复制的潜力。
J Med Virol. 2020 Nov;92(11):2341-2342. doi: 10.1002/jmv.26030. Epub 2020 Jun 2.
3
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.金刚烷类药物可能对患有神经系统疾病的 COVID-19 患者具有保护作用：多发性硬化症、帕金森病和认知障碍。
Mult Scler Relat Disord. 2020 Jul;42:102163. doi: 10.1016/j.msard.2020.102163. Epub 2020 Apr 30.
4
[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection].[金刚烷胺和美金刚对严重急性呼吸综合征冠状病毒2感染的抗炎作用]
Pol Merkur Lekarski. 2021 Feb 24;49(289):67-70.
5
Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond.盐酸美金刚在预防和治疗 COVID-19 中的潜在作用：其对烟碱型乙酰胆碱受体的拮抗作用及其他作用。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.01610-2020. Print 2020 Aug.
6
Potentially repurposing adamantanes for COVID-19.金刚烷可能对治疗新冠肺炎有新用途。
J Med Virol. 2020 Jun;92(6):531-532. doi: 10.1002/jmv.25752. Epub 2020 Mar 16.
7
Shift shown in influenza A adamantane resistance.
JAMA. 2006 Oct 4;296(13):1585-6; author reply 1586-7. doi: 10.1001/jama.296.13.1585-b.
8
Simple Two-step Procedure for the Synthesis of Memantine Hydrochloride from 1,3-Dimethyl-adamantane.由1,3 - 二甲基金刚烷合成盐酸美金刚的简单两步法
ACS Omega. 2020 Jun 25;5(26):16085-16088. doi: 10.1021/acsomega.0c01589. eCollection 2020 Jul 7.
9
Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.用于神经保护的病理激活疗法：美金刚阻断NMDA受体的机制及S-亚硝基化作用
Curr Drug Targets. 2007 May;8(5):621-32. doi: 10.2174/138945007780618472.
10
Extremely high mortality rates among hemodialysis patients with COVID-19 before the era of SARS-CoV-2 vaccination: results from a large database from the North of Poland.在 SARS-CoV-2 疫苗接种时代之前，COVID-19 血液透析患者的死亡率极高：来自波兰北部大型数据库的结果。
Pol Arch Intern Med. 2021 Jul 30;131(7-8):643-648. doi: 10.20452/pamw.16028. Epub 2021 Jun 9.
引用本文的文献
1
Potential for the Repurposing of Adamantane Antivirals for COVID-19.金刚烷类抗病毒药物在新冠病毒中的再利用潜力。
Drugs R D. 2021 Sep;21(3):267-272. doi: 10.1007/s40268-021-00351-6. Epub 2021 Jun 21.
本文引用的文献
1
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.美金刚及相关金刚烷类药物（如金刚烷胺）减轻新冠病毒疾病神经毒性作用（包括急性呼吸窘迫综合征）以及通过溶酶体效应减少病毒复制的潜力。
J Med Virol. 2020 Nov;92(11):2341-2342. doi: 10.1002/jmv.26030. Epub 2020 Jun 2.
2
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.金刚烷类药物可能对患有神经系统疾病的 COVID-19 患者具有保护作用：多发性硬化症、帕金森病和认知障碍。
Mult Scler Relat Disord. 2020 Jul;42:102163. doi: 10.1016/j.msard.2020.102163. Epub 2020 Apr 30.
3
Potentially repurposing adamantanes for COVID-19.金刚烷可能对治疗新冠肺炎有新用途。
J Med Virol. 2020 Jun;92(6):531-532. doi: 10.1002/jmv.25752. Epub 2020 Mar 16.
4
Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission.美金刚在培养的人类细胞中的溶酶体趋向性证据：细胞动力学以及美金刚对磷脂含量与组成、膜流动性和β-肾上腺素能传递的影响。
Pharmacol Toxicol. 1993 Oct;73(4):202-8. doi: 10.1111/j.1600-0773.1993.tb01564.x.
Zotero 插件